コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 activated T cells-p300 complex to IRE in the gel mobility shift assay.
2 talled elongation complexes as measured in a gel mobility shift assay.
3 mined by gel filtration chromatography and a gel mobility shift assay.
4 ed ability to bind to the tcpA promoter in a gel mobility shift assay.
5 and quantified using a native polyacrylamide gel mobility shift assay.
6 defined RNA molecules was characterized by a gel mobility shift assay.
7 aracterized by site-directed mutagenesis and gel mobility shift assay.
8 th purified FadR protein was determined by a gel mobility shift assay.
9 Similar results were obtained with a gel mobility shift assay.
10 nd to the leader sense RNA, as determined by gel mobility shift assay.
11 nd to be in the size range of 106-115 kDa by gel mobility shift assay.
12 NF-kappaB activity was determined using the gel mobility shift assay.
13 ream GRE functioned in cis and bound GR in a gel mobility shift assay.
14 c oligonucleotide substrates was analyzed by gel mobility shift assay.
15 fic binding to the gastrin CACC element in a gel mobility shift assay.
16 8 as indicated by a supershifted band in the gel mobility shift assay.
17 r protein-DNA complexes were identified by a gel mobility shift assay.
18 nd 77 +/- 6 Pm, respectively, as measured by gel mobility shift assay.
19 nary complexes that could be visualized in a gel mobility shift assay.
20 ffinity to DsrA(DII) by <or=2-fold using the gel-mobility shift assay.
21 cing the CbbR-cbbLS promoter interactions in gel mobility shift assays.
22 binding site, which we have verified here by gel mobility shift assays.
23 n using isothermal titration calorimetry and gel mobility shift assays.
24 xyl radical footprinting and electrophoretic gel mobility shift assays.
25 ipitation, DNA microarray hybridization, and gel mobility shift assays.
26 r by performing luciferase reporter gene and gel mobility shift assays.
27 DNA binding activities of wild type Pax9 in gel mobility shift assays.
28 P promoter at several sites as determined by gel mobility shift assays.
29 to have modified binding characteristics in gel mobility shift assays.
30 ed using recombinant proteins in competition gel mobility shift assays.
31 ding donors and acceptors, are determined in gel mobility shift assays.
32 ht ends of the transposon was compared using gel mobility shift assays.
33 r cisplatin-damaged DNA were investigated by gel mobility shift assays.
34 related hnRNP proteins reacted with CBF2 in gel mobility shift assays.
35 n of amyloid precursor protein (APP) mRNA in gel mobility shift assays.
36 nt plus poly(A) tail] were identified using gel mobility shift assays.
37 ifs bind specifically to p53, as assessed by gel mobility shift assays.
38 for in vitro binding to nucleic acids using gel mobility shift assays.
39 l as to the Tap-2 ISRE in vitro, as shown by gel mobility shift assays.
40 ite within their promoters, as determined by gel mobility shift assays.
41 following UV-catalyzed cross-linking and by gel mobility shift assays.
42 substrates using fluorescence anisotropy and gel mobility shift assays.
43 g of NRSF/REST to NRSE/RE-1 as determined by gel mobility shift assays.
44 from E. coli binds rsmB RNA as indicated by gel mobility shift assays.
45 ed with the SHFV 3'(-)209 RNA in competition gel mobility shift assays.
46 the COUP-TF.DNA binding complex detected in gel mobility shift assays.
47 nce was used with 3T3-L1 nuclear extracts in gel mobility shift assays.
48 2 x 10(-8) M and TGP1 can form supershift in gel mobility shift assays.
49 gions in the COL1A1 promoter was examined by gel mobility shift assays.
50 to EBNA2 and that they bind CBF1 and CBF2 in gel mobility shift assays.
51 in and DNA titration experiments analyzed by gel mobility shift assays.
52 to the promoter regions of fruA and levD in gel mobility shift assays.
53 , was investigated by DNase I protection and gel mobility shift assays.
54 d for effective MAL-SRF complex formation in gel mobility shift assays.
55 293T cells, as measured by gene reporter and gel mobility shift assays.
56 This finding was confirmed by gel mobility shift assays.
57 inding site at +18 prevented HapR binding in gel mobility shift assays.
58 uman SHMT1 promoter by deletion analyses and gel mobility shift assays.
59 -binding sites of JMJ in the ANF enhancer by gel mobility shift assays.
60 f ESE-1 to bind to oligonucleotide probes in gel mobility shift assays.
61 te to bind DNA, a prediction confirmed using gel mobility shift assays.
62 directly bound only the proximal FixK box in gel mobility-shift assays.
63 surement), fluorescence, and electrophoretic gel mobility-shift assays.
64 re tightly than the DsrA.rpoS RNA complex in gel mobility-shift assays.
65 nse element (pTRE and nTRE, respectively) in gel-mobility shift assays.
66 to heparin resin nor to heparin fragments in gel-mobility shift assays.
69 in vitro DNase I footprinting analyses, and gel mobility shift assays, a beta-spectrin gene erythroi
70 activity were assessed by an electrophoretic gel mobility shift assay and a reporter gene luciferase
72 the putative p53 recognition sequence using gel mobility shift assay and DNase I footprinting analys
76 increase AP-1 binding in an electrophoretic gel mobility shift assay and increase the expression of
81 traditional methods, such as filter binding, gel mobility shift assay and various fluorescence techni
82 elated with previously reported values using gel mobility shift assays and a similarly sized poly-dT.
85 relevance of this sequence was obtained from gel mobility shift assays and by transfection of TCC mut
88 d by this focused set of genes, we performed gel mobility shift assays and demonstrated that ChvI dir
90 ng in vivo transcriptional fusions, in vitro gel mobility shift assays and DNase I footprinting assay
91 nsus site centered at position -162 by using gel mobility shift assays and DNase I footprinting exper
96 ation results were independently verified by gel mobility shift assays and quantitative DNA footprint
97 he function of the heterodimer, we performed gel mobility shift assays and showed that the A14/A43 he
98 CCCCC -64 region of the NOS-3 gene promoter, gel mobility shift assays and site-directed mutation ana
100 plex with mispaired bases was analyzed using gel mobility shift assays and surface plasmon resonance
102 w magnesium concentrations, as determined by gel mobility shift assays and thermal dissociation profi
103 the activities of various ecdysteroids using gel mobility shift assays and transfection assays in Sch
107 on in vivo and nuclear proteins, we utilized gel mobility shift assays and UV-crosslinking studies.
108 ve EcREs to bind the EcR-B1-USP-1 complex in gel mobility shift assays and was responsible for the si
109 an oligonucleotide containing the 202-SBS in gel-mobility shift assays and to the 5'-regulatory regio
111 formation of three RNA-protein complexes by gel mobility shift assay, and UV-induced cross-linking d
112 munofluorescence studies, live cell imaging, gel mobility shift assays, and bimolecular fluorescence
114 rized by using a promoter truncation series, gel mobility shift assays, and DNase I footprinting.
115 ity isolation, DNA-binding site competition, gel mobility shift assays, and protein overexpression in
116 n analysis of the mouse Fas ligand promoter, gel mobility shift assays, and site-directed mutagenesis
119 AF-, AAF- and AP-DNA adducts, determined by gel mobility shift assay, are 33 +/- 9, 8 +/- 2 and 23 +
121 hBVR and nuclear extract containing hBVR in gel mobility-shift assay bound to AP-1 sites in the ATF-
122 directly bind the hilA and hilC promoters in gel mobility shift assays but not the flhD, fliA, hilD,
123 box consensus DNA element in electrophoretic gel mobility shift assays, but only BjFur bound the irr
124 ion was further confirmed by electrophoretic gel mobility shift assay, chromatin immunoprecipitation,
127 transfected with a SOX9 cDNA (M12/SOX9), and gel mobility shift assays confirmed binding of nuclear p
129 mobility complex with DNA in electrophoretic gel mobility shift assays corresponding to occupancy by
131 ddition to real-time PCR and immunoblotting, gel mobility shift assays, coupled with specific antibod
145 V 3'(-)209 RNA, and results from competition gel mobility shift assays demonstrated that these intera
152 equence GTCTG interfered with binding in the gel mobility shift assay, demonstrating that this pentan
154 II of DsrA ncRNA (DsrA(DII)) and A(18) by a gel-mobility shift assay, fluorescence anisotropy, and f
156 predictions were experimentally validated by gel mobility shift assays for two NrtR family representa
157 ort RNA transcripts were studied using a new gel mobility shift assay from which melting temperatures
160 ys and the formation of an ER.ERE complex in gel mobility shift assays, further indicating that the e
161 nfected Sf21 insect cells and the methods of gel mobility shift assays, gel filtration chromatography
163 , 15, 30, or 60 minutes; lysed; and used for gel mobility shift assay (GMSA) and supershift assay for
167 alyses in reporter gene assays, as well as a gel mobility shift assay, identified an LXR response ele
168 ell lines, DNase I footprinting analyses and gel mobility shift assays, identified an AHSP gene eryth
169 and normal adjacent tissue were analysed by gel mobility shift assay, immunoblotting of nuclear extr
181 tical gel filtration of native complexes and gel mobility shift assays of an maltose-binding protein-
182 Up to five complex bands are observed in gel mobility shift assays of HU binding to the 34 bp dup
183 zyme in Escherichia coli, as demonstrated by gel mobility shift assays of ligand binding and peptide-
185 proviral DNA (env-DNA) were investigated by gel mobility shift assays or by photo-cross-linking expe
188 ption-PCR, Western blotting, electrophoretic gel mobility shift assays, promoter reporter, chromatin
194 ime course luciferase assays and time course gel mobility shift assays reveal that the Smad3/4 comple
234 untranslated region of gerE mRNA in in vitro gel mobility shift assays, strongly suggesting that acon
240 h in vitro dimethyl sulfate footprinting and gel mobility shift assays, that DnaA(L366K) in either nu
242 the promoter was E2-responsive; however, in gel mobility shift assays, the estrogen receptor alpha (
246 combination with further development of the gel mobility shift assay to allow simultaneous compariso
247 hromatography and a quantitative fluorescent gel mobility shift assay to reveal an additional binding
251 or neuregulin-1-heparin interactions using a gel mobility shift assay together with an assay that mea
253 f the bent-L pathway was characterized using gel mobility shift assays, two-dimensional gel analysis,
257 proteins were evaluated by quantitative RNA gel mobility shift assays using lysed cell supernatants.
258 roperties of protein-DNA complexes formed in gel mobility shift assays using uninfected and HSV-1-inf
260 ivation of these defense genes, we performed gel-mobility shift assays using nuclear extracts from Nt
262 s has entailed the development of a modified gel mobility shift assay, utilizing fluorescence end-tag
272 nant catalytic subunit as the substrate in a gel mobility shift assay, we have identified an activity
277 bination of promoter mutational analysis and gel mobility shift assays, we have identified a binding
281 sing a combination of DNase I footprints and gel mobility shifts assays, we showed that when NAC(WT)
283 ulatory elements within the COL1A1 promoter, gel mobility shift assays were performed with nuclear ex
284 equence database, lacZ reporter fusions, and gel mobility shift assays were used to elucidate the reg
287 oter-reporter constructs and electrophoretic gel mobility shift assays were utilized to examine COL1A
288 R with the misR promoter was demonstrated by gel mobility shift assays, where MisR approximately P ex
289 ping H-NS/ToxT binding sites was observed in gel mobility shift assays, where ToxT was found to displ
290 nsensus sequence, Southwestern analysis, and gel mobility shift assays with antibodies identify MAZ a
292 ound that it binds purified TBP and TFIIB in gel mobility shift assays with cooperative enhancement o
293 ing to an estrogen responsive DNA element in gel mobility shift assays with EC(50)s of about 0.1 micr
295 s not exhibit DNA-binding activity in native gel mobility shift assays with promoter regions of the p
297 plex by isothermal titration calorimetry and gel mobility shift assays with rRNA and proteins from th
300 series of overlapping trcR PCR fragments in gel mobility shift assays with TrcR, an AT-rich region o
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。